Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, ...
My team and I set out to test whether GLP-1 drugs — medications like semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound), originally developed for diabetes and then approved for ...
Studies suggest GLP-1 drugs like Semaglutide and Tirzepatide may help reduce cravings for alcohol, opioids, and nicotine. Researchers say these medications influence the brain’s reward system, ...
Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new government-funded research. The study was small — just 48 adults — and lasted just ...
This article was reviewed by Darragh O’Carroll, MD. Key takeaways: Common semaglutide side effects include nausea, vomiting, ...
The Print on MSN
How GLP-1 ‘wonder drugs’ for diabetes & obesity also reduce risk of addiction to liquor, smoking & more
A large study of US veterans suggests that diabetes and weight-loss medicines may curb cravings and lower severe addiction outcomes, though clinical trials are still needed.
Researchers report that tirzepatide, the active ingredient in Mounjaro, reduced alcohol consumption, binge drinking, and relapse-like behavior in animals. These findings highlight its potential as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results